Athena Athena

X

Digital content for PepGen

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
PepGen
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
245 Main St, Cambridge, MA 02142
Telephone
Telephone
+44 1865 618 820
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.globenewswire.com//news-release/2024/03/13/2845838/0/en/PepGen-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
13 Mar 2024

https://www.globenewswire.com//news-release/2024/03/13/2845286/0/en/PepGen-Receives-U-S-FDA-Orphan-Drug-and-Rare-Pediatric-Disease-Designations-for-PGN-EDO51-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html

GLOBENEWSWIRE
13 Mar 2024

https://www.globenewswire.com//news-release/2024/03/06/2841759/0/en/PepGen-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Corporate-Developments.html

GLOBENEWSWIRE
06 Mar 2024

https://www.globenewswire.com//news-release/2024/03/04/2839407/0/en/PepGen-Announces-Clearance-of-CTA-by-UK-Medicines-Healthcare-Products-Regulatory-Agency-to-Begin-CONNECT2-EDO51-a-Phase-2-Clinical-Trial-designed-to-support-potential-accelerated-a.html

GLOBENEWSWIRE
04 Mar 2024

https://www.globenewswire.com//news-release/2024/02/20/2831795/0/en/PepGen-Receives-U-S-FDA-Fast-Track-Designation-for-PGN-EDODM1-for-the-Treatment-of-Myotonic-Dystrophy-Type-1.html

GLOBENEWSWIRE
20 Feb 2024

https://www.globenewswire.com//news-release/2024/02/07/2825084/0/en/PepGen-Announces-Pricing-of-80-1-Million-Underwritten-Offering-of-Common-Stock.html

GLOBENEWSWIRE
07 Feb 2024

https://www.globenewswire.com//news-release/2024/01/17/2810588/0/en/Mary-Beth-DeLena-Joins-PepGen-as-General-Counsel-and-Secretary.html

GLOBENEWSWIRE
17 Jan 2024

https://www.globenewswire.com//news-release/2024/01/08/2805272/0/en/PepGen-Announces-First-Patient-Dosed-in-CONNECT1-EDO51-Phase-2-Clinical-Trial-of-PGN-EDO51-for-Duchenne-Muscular-Dystrophy-Patients-Amenable-to-Exon-51-Skipping.html

GLOBENEWSWIRE
08 Jan 2024

https://www.globenewswire.com//news-release/2023/12/18/2797798/0/en/PepGen-Announces-First-Patient-Dosed-in-Phase-1-FREEDOM-DM1-Clinical-Trial-of-PGN-EDODM1-for-Myotonic-Dystrophy-Type-1-DM1.html

GLOBENEWSWIRE
18 Dec 2023

https://www.globenewswire.com//news-release/2023/11/15/2780968/0/en/PepGen-Announces-Appointment-of-Howard-Mayer-M-D-to-Board-of-Directors.html

GLOBENEWSWIRE
15 Nov 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY